| 1 |
34977030 | The Tongue Squamous Carcinoma Cell Line Cal27 Primarily Employs Integrin α6β4-Containing Type II Hemidesmosomes for Adhesion Which Contribute to Anticancer Drug Sensitivity. | 2021 |
1 |
| 2 |
32384236 | Cyclic RGD-Conjugated Hyaluronate Dot Bearing Cleavable Doxorubicin for Multivalent Tumor Targeting. | 2020 Jun 8 |
2 |
| 3 |
27533248 | Doxorubicin-triggered self-assembly of native amphiphilic peptides into spherical nanoparticles. | 2016 Sep 6 |
1 |
| 4 |
24513318 | Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier. | 2014 Apr |
1 |
| 5 |
24757954 | The C(RgdyK)-conjugated Fe3O4 nanoparticles with high drug load for dual-targeting integrin alpha(v)beta3-expressing cancer cells. | 2014 Jul |
3 |
| 6 |
23623323 | The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells. | 2013 Jul |
3 |
| 7 |
18578486 | In vitro and in vivo evaluation of doxorubicin conjugates with the divalent peptide E-[c(RGDfK)2] that targets integrin alphavbeta3. | 2008 Jul |
1 |
| 8 |
18710273 | Peptide-targeted polyglutamic acid doxorubicin conjugates for the treatment of alpha(v)beta(6)-positive cancers. | 2008 Sep |
1 |